Case Reports in Clinical Medicine

Volume 10, Issue 10 (October 2021)

ISSN Print: 2325-7075   ISSN Online: 2325-7083

Google-based Impact Factor: 0.2  Citations  

Clinical Efficacy of Shenmai Injection in the Treatment of Cerebral Vasospasm after Ruptured Aneurysm Surgery

HTML  XML Download Download as PDF (Size: 525KB)  PP. 253-263  
DOI: 10.4236/crcm.2021.1010033    428 Downloads   814 Views  

ABSTRACT

Objective: To investigate the therapeutic effect of Shenmai Injection on postoperative cerebral vasospasm in patients with ruptured aneurysms. Methods: Seventy patients undergoing craniotomy for ruptured aneurysms in our hospital were selected as study subjects and randomly divided into control (n = 33) and research (n = 37) groups, they were treated with nimodipine and nimodipine combined with Shenmai injection after operation. The blood flow velocity in the middle cerebral artery (MCA) before and at 1, 3, 7, 11 and 14 days after surgery and the incidence of cerebral vasospasm during these days were compared, and the GCS scores at 14 days postoperatively and GOS scores at 6 months postoperatively were compared between the two groups. Results: There were no statistically significant differences in the occurrence of cerebral vasospasm, GCS or GOS scores between the two groups (P > 0.05), but the period of postoperative cerebral vasospasm in the study group was significantly shorter than that in the control group. Conclusion: Shenmai injection has the effect of shortening the cycle of occurrence of cerebral vasospasm after the operation of ruptured aneurysms, promoting patients to recover as early as possible and reducing their physical and mental burden.

Share and Cite:

Wu, T. , Fu, J. , Jin, X. , Chen, Q. , Huang, H. , Chen, S. , Zhou, J. and Xu, L. (2021) Clinical Efficacy of Shenmai Injection in the Treatment of Cerebral Vasospasm after Ruptured Aneurysm Surgery. Case Reports in Clinical Medicine, 10, 253-263. doi: 10.4236/crcm.2021.1010033.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.